Novel device to make blood testing pain-free for diabetics

Image
Press Trust of India London
Last Updated : Jan 06 2019 | 3:10 PM IST

A novel microneedle patch to reliably monitor blood-sugar levels may soon offer diabetics a pain-free alternative to pricking their fingers several times a day to take a blood test, scientists say.

The prototype, designed by researchers at KTH Royal Institute of Technology in Sweden, was successfully tested on a human subject, and completion of the system for clinical tests is now underway.

Continuous monitoring is a way to safely and reliably lower blood glucose -- giving the user a full picture of their glucose levels throughout the day and helping them avoid severe hypoglycemia.

However, the continuous glucose monitoring systems (known as CGMS) in use are uncomfortable, since they require a minimum 7mm needle inserted into the skin.

Due to their size, they take measurements in the fat tissue -- not the most ideal location.

The newly developed microneedle patch that is 50 times smaller than the needles used in today's CGM systems, researchers said.

The combination of the patch and an extremely miniaturised three-electrode enzymatic sensor was shown in a recent study to be capable of correctly and dynamically tracking blood glucose levels over time, with a delay of about 10 minutes, when applied to a human subject's forearm.

One of the researchers, doctoral student Federico Ribet, said the next steps are to develop a transferable adhesive patch, along with algorithms and embedded electronics for a fully-realised system to take to clinical trial.

"Our solution is painless to the user. We measure directly in the skin, and there are no nerve receptors that detect pain -- just a fine mesh of very tiny blood vessels," said Ribet.

Within the dermis, the hollow microneedles rely on natural capillary action to fill up with interstitial fluid, the liquid surrounding the cells in the skin. Nutrients like sugar, diffuse out of the blood capillaries in this fluid to reach the cells.

"An important distinction is that unlike commercially available CGMS which measure the subcutaneous fat tissue, ours measures within the skin less than 1mm deep, where the interstitial fluid follows closer and more homogeneously the blood-glucose oscillations," he said.

This would offer an alternative to pricking one's fingers several times a day to take a blood test, although a user would still occasionally have to do so in order to recalibrate the sensor and get the most accurate and immediate readings.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jan 06 2019 | 3:10 PM IST

Next Story